Page 92 - 2021 Taiwan Food and Drug Administration Annual Report

September September 16 Held the “2020 APEC International Workshop on Food
Safety and Threat from New Psychoactive Substances”.
September 16
to September 18 Participated in the “2020 KIDS-APEC PV CoE Training”
September 17 teleconferencing seminar held by KIDS in Korea.

September 17 Organized the “Emerging Biotechnology Food Issues
Symposium”, and invited biotechnology and social
September 18 science experts to share issues related to emerging
biotechnology.
September 22
to September 24 Participated in the 18th APEC LSIF Policy Dialogue
videoconference. In the meeting, experts and
October October 5 to representatives among APEC economies would gather
October 6 and discuss about ‘Looking forward to the next decade
of the life science’, ‘Utilizing digital technology for the
October 15 to innovation’ and ‘Accelerating the regulatory convergence’
October 16 and related policies.
October 22 to
October 23 Participated in the 18th APEC LSIF Planning Group
Meeting. In the meeting, the Secretariat and working
October 30 groups would give brief updates, meanwhile, the
to November 15 representatives would endorse several COVID-19
statements. In addition, many experts from industries,
90 regulatory authorities and academia would share
GLႇHUHQW UHVHDUFK NQRZOHGJHV

Held the “Briefing on the Review System of Artificial
Intelligence Technology Medical Devices Before
Market Launch in Various Countries” in Taipei and
Kaohsiung to enhance the understanding of smart
medical device management laws and regulations of the
telecommunications industry.

TFDA held the 2020 National Pharmaceutical
Administration Seminar, which includes special reports
on pharmaceutical administration and inspection
experience sharing of health bureaus. The prosecutors
RI 3LQJWXQJ 'LVWULFW 3URVHFXWRUV 2ႈFH ZDV LQYLWHG WR JLYH
a keynote speech. And pharmaceutical administration
proposals were discussed with health bureaus.

Participated in the 8th Joint Conference of Taiwan and
Japan on Medical Products Regulation.

Held the international video conference of the In Vitro
Diagnostic Medical Device Working Group (WG2) of the
Asian Harmonization Working Party (AHWP). A total of
26 representatives from governments and industries of
various countries attended the conference to promote
the development of international guidelines for in vitro
diagnostic medical devices (IVD).

Held the “2020 International Medical Device Regulations
Seminar”, and invited industry and government
representatives from the EU, Thailand to discuss topics
such as the latest medical devices regulations of the
EU and the ASEAN, and introduce AI medical devices,
software validation and international standards for risk
management.